Literature DB >> 11499557

Reappraisal of serum beta2-microglobulin as marker of GFR.

C Bianchi1, C Donadio, G Tramonti, C Consani, P Lorusso, G Rossi.   

Abstract

INTRODUCTION: Beta 2 microglobulin (beta2M) is filtered by the glomeruli and reabsorbed by the proximal tubular cells where it is metabolized. Its plasma concentration increases with decreasing renal function. AIM: To compare serum creatinine (Cr) and serum beta2M as markers of GFR. PATIENTS AND METHODS: In 160 adult patients, with various kidney diseases and different GFR, serum Cr (autoanalyzer), serum beta2M (RIA) and GFR (bladder cumulative method using 99mTc-DTPA as glomerular tracer) were measured in the same day.
RESULTS: A linear relationship was observed between In GFR and both In serum Cr (lnCr=3.112-0.716 lnGFR; r=0.92) and ln serum beta2M (lnbeta2M= 4.274-0.814 lnGFR; r = 0.90). With decreasing GFR the increase in serum beta2M was higher than that of serum Cr (see regression coefficients that are significantly different). The normal upper limit of serum Cr corresponds to a GFR 48.1 mL/min while that of serum beta2M to a GFR 65.0. With decreasing GFR the increase of serum beta2M occurs before than that of serum Cr.
CONCLUSIONS: With declining renal function, serum beta2M increases more and before than serum Cr. Serum beta2M is a good endogenous marker of GFR, better than serum Cr.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11499557     DOI: 10.1081/jdi-100104725

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  29 in total

1.  Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.

Authors:  Brad C Astor; Tariq Shafi; Ron C Hoogeveen; Kunihiro Matsushita; Christie M Ballantyne; Lesley A Inker; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2012-02-04       Impact factor: 8.860

Review 2.  Biomarkers in chronic kidney disease, from kidney function to kidney damage.

Authors:  Salvador Lopez-Giacoman; Magdalena Madero
Journal:  World J Nephrol       Date:  2015-02-06

3.  Circulating Beta-2 Microglobulin and Risk of Cancer: The Atherosclerosis Risk in Communities Study (ARIC).

Authors:  Anna E Prizment; Amy M Linabery; Pamela L Lutsey; Elizabeth Selvin; Heather H Nelson; Aaron R Folsom; Timothy R Church; Charles G Drake; Elizabeth A Platz; Corinne Joshu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02-05       Impact factor: 4.254

4.  Genome-wide association study identified the human leukocyte antigen region as a novel locus for plasma beta-2 microglobulin.

Authors:  Adrienne Tin; Brad C Astor; Eric Boerwinkle; Ron C Hoogeveen; Josef Coresh; Wen Hong Linda Kao
Journal:  Hum Genet       Date:  2013-02-16       Impact factor: 4.132

5.  Urine Beta2-Microglobulin Is an Early Marker of Renal Involvement in LPI.

Authors:  Mari Kärki; Kirsti Näntö-Salonen; Harri Niinikoski; Laura M Tanner
Journal:  JIMD Rep       Date:  2015-06-30

6.  Comparison of serum beta 2-microglobulin and 24 hour urinary creatinine clearance as a prognostic factor in multiple myeloma.

Authors:  Jae-Pil Yun; Cheolwon Suh; Eunkyoung Lee; Jai Won Chang; Won Seok Yang; Jung Sik Park; Su-Kil Park
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

7.  Beta-2 microglobulin-based equation for estimating glomerular filtration rates in Japanese children and adolescents.

Authors:  Yohei Ikezumi; Osamu Uemura; Takuhito Nagai; Kenji Ishikura; Shuichi Ito; Hiroshi Hataya; Naoya Fujita; Yuko Akioka; Tetsuji Kaneko; Kazumoto Iijima; Masataka Honda
Journal:  Clin Exp Nephrol       Date:  2014-08-01       Impact factor: 2.801

8.  Early detection of acute kidney injury by serum cystatin C in critically ill children.

Authors:  Neamatollah Ataei; Behnaz Bazargani; Sonbol Ameli; Abbas Madani; Faezeh Javadilarijani; Mastaneh Moghtaderi; Arash Abbasi; Sedigheh Shams; Fatemeh Ataei
Journal:  Pediatr Nephrol       Date:  2013-08-30       Impact factor: 3.714

9.  Serum β2-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still's disease.

Authors:  Kuninobu Wakabayashi; Shigeko Inokuma; Erika Matsubara; Kae Onishi; Hiromitsu Asashima; Shinichiro Nakachi; Kiyofumi Hagiwara
Journal:  Clin Rheumatol       Date:  2013-03-16       Impact factor: 2.980

10.  Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults.

Authors:  Meredith C Foster; Lesley A Inker; Andrew S Levey; Elizabeth Selvin; John Eckfeldt; Stephen P Juraschek; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2013-03-19       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.